Skip to main content
Top
Published in: Journal of Neurology 11/2010

01-11-2010 | Original Communication

Huntington’s disease: changes in saccades and hand-tapping over 3 years

Authors: Chrystalina A. Antoniades, Zheyu Xu, Sarah L. Mason, R. H. S. Carpenter, Roger A. Barker

Published in: Journal of Neurology | Issue 11/2010

Login to get access

Abstract

Saccades and hand-tapping are both potential biomarkers in patients with Huntington’s disease (HD). While it is well known that patients with manifest Huntington’s disease display abnormalities in both of these tasks, less is known about how these abnormalities progress over time, or to what extent premanifest patients are affected. This study was designed to address these issues. We examined premanifest and manifest Huntington’s cohorts, together with a group of controls, over a 3-year period. Data were collected using a portable head-mounted saccadometer and a computerised hand-tapping device. Both premanifest and manifest Huntington’s disease patients display significant and systematic changes from year to year in the parameters describing saccadic latency, while controls remain unchanged. By contrast, although hand-tapping was abnormal in HD patients, annual changes were much smaller. Measuring the rate of progression of saccadic abnormalities in manifest HD patients may provide a way to track disease progression, and thus help to evaluate novel therapies to modify the disease. The clear-cut progression in saccadic abnormalities in the premanifest group may prove useful in the future as a predictor of time to disease onset.
Literature
1.
go back to reference Ali FR, Michell AW, Barker RA, Carpenter RH (2006) The use of quantitative oculometry in the assessment of Huntington’s disease. Exp Brain Res Exp Hirnforsch 169:237–245CrossRef Ali FR, Michell AW, Barker RA, Carpenter RH (2006) The use of quantitative oculometry in the assessment of Huntington’s disease. Exp Brain Res Exp Hirnforsch 169:237–245CrossRef
2.
go back to reference Antoniades CA, Altham PM, Mason SL, Barker RA, Carpenter R (2007) Saccadometry: a new tool for evaluating presymptomatic Huntington patients. Neuroreport 18:1133–1136CrossRefPubMed Antoniades CA, Altham PM, Mason SL, Barker RA, Carpenter R (2007) Saccadometry: a new tool for evaluating presymptomatic Huntington patients. Neuroreport 18:1133–1136CrossRefPubMed
3.
go back to reference Biglan KM, Ross CA, Langbehn DR, Aylward EH, Stout JC, Queller S, Carlozzi NE, Duff K, Beglinger LJ, Paulsen JS (2009) Motor abnormalities in premanifest persons with Huntington’s disease: the PREDICT-HD study. Mov Disord 24:1763–1772CrossRefPubMed Biglan KM, Ross CA, Langbehn DR, Aylward EH, Stout JC, Queller S, Carlozzi NE, Duff K, Beglinger LJ, Paulsen JS (2009) Motor abnormalities in premanifest persons with Huntington’s disease: the PREDICT-HD study. Mov Disord 24:1763–1772CrossRefPubMed
4.
go back to reference Blekher TJS, Marshall J, White K, Hui S, Weaver M, Gray J, Yee R, Stout JC, Beristain X, Wojcieszek J, Foroud T (2006) Saccades in presymptomatic and early stages of Huntington disease. Neurology 67:394–399CrossRefPubMed Blekher TJS, Marshall J, White K, Hui S, Weaver M, Gray J, Yee R, Stout JC, Beristain X, Wojcieszek J, Foroud T (2006) Saccades in presymptomatic and early stages of Huntington disease. Neurology 67:394–399CrossRefPubMed
5.
go back to reference Blekher T, Weaver MR, Cai X, Hui S, Marshall J, Jackson JG, Wojcieszek J, Yee RD, Foroud TM (2009) Test-retest reliability of saccadic measures in subjects at risk for Huntington disease. Invest Ophthalmol Vis Sci 50:5707–5711CrossRefPubMed Blekher T, Weaver MR, Cai X, Hui S, Marshall J, Jackson JG, Wojcieszek J, Yee RD, Foroud TM (2009) Test-retest reliability of saccadic measures in subjects at risk for Huntington disease. Invest Ophthalmol Vis Sci 50:5707–5711CrossRefPubMed
6.
go back to reference Blekher TMYR, Kirkwood SC, Hake AM, Stout JC, Weaver MR, Foroud TM (2004) oculomotor control in asymptomatic and recently diagnosed individuals with the genetic marker for Huntington’s disease. In: Vision research, pp 2729–2736 Blekher TMYR, Kirkwood SC, Hake AM, Stout JC, Weaver MR, Foroud TM (2004) oculomotor control in asymptomatic and recently diagnosed individuals with the genetic marker for Huntington’s disease. In: Vision research, pp 2729–2736
7.
go back to reference Carpenter RH, Williams ML (1995) Neural computation of log likelihood in control of saccadic eye movements. Nature 377:59–62CrossRefPubMed Carpenter RH, Williams ML (1995) Neural computation of log likelihood in control of saccadic eye movements. Nature 377:59–62CrossRefPubMed
8.
go back to reference Carpenter RHS (1994) SPIC: a PC-based system for rapid measurement of saccadic responses. J Physiol 4P:480 Carpenter RHS (1994) SPIC: a PC-based system for rapid measurement of saccadic responses. J Physiol 4P:480
9.
go back to reference Garcia Ruiz PJ, Hernandez J, Cantarero S, Bartolome M, Sanchez Bernardos V, Garcia de Yebenez J (2002) Bradykinesia in Huntington’s disease. A prospective, follow-up study. J Neurol 249:437–440CrossRefPubMed Garcia Ruiz PJ, Hernandez J, Cantarero S, Bartolome M, Sanchez Bernardos V, Garcia de Yebenez J (2002) Bradykinesia in Huntington’s disease. A prospective, follow-up study. J Neurol 249:437–440CrossRefPubMed
10.
go back to reference Golding CVP, Danchaivijitr C, Hodgson TL, Tabrizi SJ, Kennard C (2006) Identification of an oculomotor biomarker of preclinical Huntington disease. Neurology 67:485–487CrossRefPubMed Golding CVP, Danchaivijitr C, Hodgson TL, Tabrizi SJ, Kennard C (2006) Identification of an oculomotor biomarker of preclinical Huntington disease. Neurology 67:485–487CrossRefPubMed
11.
go back to reference Hicks SL, Robert MP, Golding CV, Tabrizi SJ, Kennard C (2008) Oculomotor deficits indicate the progression of Huntington’s disease. Prog Brain Res 171:555–558CrossRefPubMed Hicks SL, Robert MP, Golding CV, Tabrizi SJ, Kennard C (2008) Oculomotor deficits indicate the progression of Huntington’s disease. Prog Brain Res 171:555–558CrossRefPubMed
12.
go back to reference Hikosaka O, Takikawa Y, Kawagoe R (2000) Role of the basal ganglia in the control of purposive saccadic eye movements. Physiol Rev 80:953–978PubMed Hikosaka O, Takikawa Y, Kawagoe R (2000) Role of the basal ganglia in the control of purposive saccadic eye movements. Physiol Rev 80:953–978PubMed
13.
go back to reference Ho AK, Sahakian BJ, Brown RG, Barker RA, Hodges JR, Ane MN, Snowden J, Thompson J, Esmonde T, Gentry R, Moore JW, Bodner T (2003) Profile of cognitive progression in early Huntington’s disease. Neurology 61:1702–1706PubMed Ho AK, Sahakian BJ, Brown RG, Barker RA, Hodges JR, Ane MN, Snowden J, Thompson J, Esmonde T, Gentry R, Moore JW, Bodner T (2003) Profile of cognitive progression in early Huntington’s disease. Neurology 61:1702–1706PubMed
14.
go back to reference Isoda M, Hikosaka O (2008) Role for subthalamic nucleus neurons in switching from automatic to controlled eye movement. J Neurosci 28:7209–7218CrossRefPubMed Isoda M, Hikosaka O (2008) Role for subthalamic nucleus neurons in switching from automatic to controlled eye movement. J Neurosci 28:7209–7218CrossRefPubMed
15.
go back to reference Kirkwood SC, Siemers E, Bond C, Conneally PM, Christian JC, Foroud T (2000) Confirmation of subtle motor changes among presymptomatic carriers of the Huntington disease gene. Arch Neurol 57:1040–1044CrossRefPubMed Kirkwood SC, Siemers E, Bond C, Conneally PM, Christian JC, Foroud T (2000) Confirmation of subtle motor changes among presymptomatic carriers of the Huntington disease gene. Arch Neurol 57:1040–1044CrossRefPubMed
16.
go back to reference Kirkwood SC, Siemers E, Hodes ME, Conneally PM, Christian JC, Foroud T (2000) Subtle changes among presymptomatic carriers of the Huntington’s disease gene. J Neurol Neurosurg Psychiatry 69:773–779CrossRefPubMed Kirkwood SC, Siemers E, Hodes ME, Conneally PM, Christian JC, Foroud T (2000) Subtle changes among presymptomatic carriers of the Huntington’s disease gene. J Neurol Neurosurg Psychiatry 69:773–779CrossRefPubMed
17.
go back to reference Kirkwood SC, Siemers E, Stout JC, Hodes ME, Conneally PM, Christian JC, Foroud T (1999) Longitudinal cognitive and motor changes among presymptomatic Huntington disease gene carriers. Arch Neurol 56:563–568CrossRefPubMed Kirkwood SC, Siemers E, Stout JC, Hodes ME, Conneally PM, Christian JC, Foroud T (1999) Longitudinal cognitive and motor changes among presymptomatic Huntington disease gene carriers. Arch Neurol 56:563–568CrossRefPubMed
18.
go back to reference Klein C, Foerster F, Hartnegg K, Fischer B (2005) Lifespan development of pro- and anti-saccades: multiple regression models for point estimates. Brain Res Dev Brain Res 160:113–123CrossRefPubMed Klein C, Foerster F, Hartnegg K, Fischer B (2005) Lifespan development of pro- and anti-saccades: multiple regression models for point estimates. Brain Res Dev Brain Res 160:113–123CrossRefPubMed
19.
go back to reference Kolmogorov A (1941) Confidence limits for an unknown distribution function. Ann Math Stat 23:525–540 Kolmogorov A (1941) Confidence limits for an unknown distribution function. Ann Math Stat 23:525–540
20.
go back to reference Langbehn DR, Brinkman RR, Falush D, Paulsen JS, Hayden MR (2004) A new model for prediction of the age of onset and penetrance for Huntington’s disease based on CAG length. Clin Genet 65:267–277CrossRefPubMed Langbehn DR, Brinkman RR, Falush D, Paulsen JS, Hayden MR (2004) A new model for prediction of the age of onset and penetrance for Huntington’s disease based on CAG length. Clin Genet 65:267–277CrossRefPubMed
21.
go back to reference Lasker AG, Zee DS (1997) Ocular motor abnormalities in Huntington’s disease. Vis Res 37:3639–3645CrossRefPubMed Lasker AG, Zee DS (1997) Ocular motor abnormalities in Huntington’s disease. Vis Res 37:3639–3645CrossRefPubMed
22.
go back to reference Lasker AG, Zee DS, Hain TC, Folstein SE, Singer HS (1987) Saccades in Huntington’s disease: initiation defects and distractibility. Neurology 37:364–370PubMed Lasker AG, Zee DS, Hain TC, Folstein SE, Singer HS (1987) Saccades in Huntington’s disease: initiation defects and distractibility. Neurology 37:364–370PubMed
23.
go back to reference Lasker AG, Zee DS, Hain TC, Folstein SE, Singer HS (1988) Saccades in Huntington’s disease: slowing and dysmetria. Neurology 38:427–431PubMed Lasker AG, Zee DS, Hain TC, Folstein SE, Singer HS (1988) Saccades in Huntington’s disease: slowing and dysmetria. Neurology 38:427–431PubMed
24.
go back to reference Lasker G, Adrian ZD (1997) Ocular motor abnormalities in Huntington’s disease. Vis Res 37:3639–3645CrossRefPubMed Lasker G, Adrian ZD (1997) Ocular motor abnormalities in Huntington’s disease. Vis Res 37:3639–3645CrossRefPubMed
25.
go back to reference Leigh RJKC (2004) Using saccades as a research tool in the clinical neurosciences. Brain 127:460–477CrossRefPubMed Leigh RJKC (2004) Using saccades as a research tool in the clinical neurosciences. Brain 127:460–477CrossRefPubMed
26.
go back to reference Leigh RJ, Newman SA, Folstein SE, Lasker AG, Jensen BA (1983) Abnormal ocular motor control in Huntington’s disease. Neurology 33:1268–1275PubMed Leigh RJ, Newman SA, Folstein SE, Lasker AG, Jensen BA (1983) Abnormal ocular motor control in Huntington’s disease. Neurology 33:1268–1275PubMed
27.
go back to reference Leigh RJZD (2006) The neurology of eye movements Leigh RJZD (2006) The neurology of eye movements
28.
go back to reference Michell AW, Goodman AO, Silva AH, Lazic SE, Morton AJ, Barker RA (2008) Hand tapping: a simple, reproducible, objective marker of motor dysfunction in Huntington’s disease. J Neurol Michell AW, Goodman AO, Silva AH, Lazic SE, Morton AJ, Barker RA (2008) Hand tapping: a simple, reproducible, objective marker of motor dysfunction in Huntington’s disease. J Neurol
29.
go back to reference Ober JK, Przedpelska-Ober E, Gryncewicz W, Dylak J, Carpenter RS, Ober JJ (2003) Hand-held system for ambulatory measurement of saccadic durations of neurological patients. In: Modelling and measurement in medicine Ober JK, Przedpelska-Ober E, Gryncewicz W, Dylak J, Carpenter RS, Ober JJ (2003) Hand-held system for ambulatory measurement of saccadic durations of neurological patients. In: Modelling and measurement in medicine
30.
go back to reference Paulsen JS, Langbehn DR, Stout JC, Aylward E, Ross CA, Nance M, Guttman M, Johnson S, McDonald M, Beglinger LJ, Duff K, Kayson E, Biglan K, Shoulson I, Oakes D, Hayden M (2007) Detection of Huntington’s disease decades before diagnosis: the predict HD study. J Neurol Neurosurg Psychiatry Paulsen JS, Langbehn DR, Stout JC, Aylward E, Ross CA, Nance M, Guttman M, Johnson S, McDonald M, Beglinger LJ, Duff K, Kayson E, Biglan K, Shoulson I, Oakes D, Hayden M (2007) Detection of Huntington’s disease decades before diagnosis: the predict HD study. J Neurol Neurosurg Psychiatry
31.
go back to reference Peinemann A, Schuller S, Pohl C, Jahn T, Weindl A, Kassubek J (2005) Executive dysfunction in early stages of Huntington’s disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study. J Neurol Sci 239:11–19CrossRefPubMed Peinemann A, Schuller S, Pohl C, Jahn T, Weindl A, Kassubek J (2005) Executive dysfunction in early stages of Huntington’s disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study. J Neurol Sci 239:11–19CrossRefPubMed
32.
go back to reference Peltsch A, Hoffman A, Armstrong I, Pari G, Munoz DP (2008) Saccadic impairments in Huntington’s disease. Exp Brain Res Exp Hirnforsch 186:457–469CrossRef Peltsch A, Hoffman A, Armstrong I, Pari G, Munoz DP (2008) Saccadic impairments in Huntington’s disease. Exp Brain Res Exp Hirnforsch 186:457–469CrossRef
33.
go back to reference Rupp J, Blekher T, Jackson J, Beristain X, Marshall J, Hui S, Wojcieszek J, Foroud T (2010) Progression in prediagnostic Huntington disease. J Neurol Neurosurg Psychiatry 81:379–384CrossRefPubMed Rupp J, Blekher T, Jackson J, Beristain X, Marshall J, Hui S, Wojcieszek J, Foroud T (2010) Progression in prediagnostic Huntington disease. J Neurol Neurosurg Psychiatry 81:379–384CrossRefPubMed
34.
go back to reference Rupp J, Blekher T, Jackson J, Beristain X, Marshall J, Hui S, Wojcieszek J, Foroud T (2009) Progression in prediagnostic huntington disease. J Neurol Neurosurg Psychiatry Rupp J, Blekher T, Jackson J, Beristain X, Marshall J, Hui S, Wojcieszek J, Foroud T (2009) Progression in prediagnostic huntington disease. J Neurol Neurosurg Psychiatry
35.
go back to reference Saft C, Andrich J, Meisel NM, Przuntek H, Muller T (2006) Assessment of simple movements reflects impairment in Huntington’s disease. Mov Disord 21:1208–1212CrossRefPubMed Saft C, Andrich J, Meisel NM, Przuntek H, Muller T (2006) Assessment of simple movements reflects impairment in Huntington’s disease. Mov Disord 21:1208–1212CrossRefPubMed
36.
go back to reference Snowden JS, Craufurd D, Thompson J, Neary D (2002) Psychomotor, executive, and memory function in preclinical Huntington’s disease. J Clin Exp Neuropsychol 24:133–145CrossRefPubMed Snowden JS, Craufurd D, Thompson J, Neary D (2002) Psychomotor, executive, and memory function in preclinical Huntington’s disease. J Clin Exp Neuropsychol 24:133–145CrossRefPubMed
37.
38.
go back to reference Tsai Tzu-Tung LA, David Zee (1995) Visual attention in Huntington’s disease: the effect of cueing on saccade latencies and manual reaction times. Neuropsychologia 33:1617–1626CrossRef Tsai Tzu-Tung LA, David Zee (1995) Visual attention in Huntington’s disease: the effect of cueing on saccade latencies and manual reaction times. Neuropsychologia 33:1617–1626CrossRef
Metadata
Title
Huntington’s disease: changes in saccades and hand-tapping over 3 years
Authors
Chrystalina A. Antoniades
Zheyu Xu
Sarah L. Mason
R. H. S. Carpenter
Roger A. Barker
Publication date
01-11-2010
Publisher
Springer-Verlag
Published in
Journal of Neurology / Issue 11/2010
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-010-5632-2

Other articles of this Issue 11/2010

Journal of Neurology 11/2010 Go to the issue